Compare MGM Resorts International (MGM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs Tenet Healthcare Corporation — how do they compare? MGM Resorts International trades at $30.16 (market cap $7.55B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 2.8× MGM Resorts International's market cap, and MGM Resorts International pays a 0.03% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold MGM Resorts International for 91 Days and Tenet Healthcare Corporation for 15 Days on average.
| MGM | THC | |
|---|---|---|
Market Cap | $7.55B | $20.92B |
Volume | 5,398,410 | 455,764 |
Sector | Consumer Cyclical | Health |
52-Week High | $50.69 | $280.77 |
52-Week Low | $30.00 | $161.37 |
Typical Hold Time | 91 Days | 15 Days |
Enterprise Value | $34.85B | $32.00B |
Dividend Yield | 0.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International (MGM) trades at $30.01, down 1.74% over 24 hours amid recent deal volatility. The stock is technically bearish with key support at $30, while fundamentals show revenue growth to $17.54B in 2025 but declining net margins to 2.4%. Recent news highlights a collapsed $48.30-per-share acquisition offer from Barry Diller's People Inc., contributing to negative sentiment and a 17% stock decline in 2026.
MGM's investment outlook is mixed: analyst consensus is bullish with a $49.85 price target, but risks include earnings volatility, high debt, and integration challenges from potential M&A. The stock offers value with a low P/S of 0.45, yet investors face headwinds from competitive pressures and macroeconomic sensitivity in the gaming sector.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
